R A Sells, R R Owen, R R New, I T Gilmore. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Clinical Trials as TopicDoxorubicin/administration & dosageDoxorubicin/adverse effectsHumansLiposomes/administration & dosageNeoplasms/drug therapy
Substances: See more » LiposomesDoxorubicin
Year: 1987 PMID: 2887906 DOI: 10.1016/s0140-6736(87)93011-x
Source DB: PubMed Journal: Lancet ISSN: 0140-6736 Impact factor: 79.321